-2.63%
0.78%
-11.00%
-7.50%
7.92%
-10.69%
3.19%
AI Spotlight on RJF
Company Description
Laboratorio Reig Jofre, S.A., a pharmaceutical company, researches, develops, manufactures, and markets pharmaceutical products and food supplements.The company offers prescription medicines, OTCs, medical devices, and cosmetics.Its products include pharmaceutical technologies products, such as antibiotics, and injectable and other products; specialty pharmacare products, which include skin, hair, and nail health, joint health and pain, women's health, respiratory/ENT, and pediatrics; and consumer healthcare products under the Forté Pharma brand.
The company also provides CDMO and CMO services.It sells its products directly in 7 countries and through business partners in approximately 70 countries.The company was founded in 1929 and is based in Sant Joan Despí, Spain.
Laboratorio Reig Jofre, S.A. is a subsidiary of Reig Jofre Investments SL.
Market Data
| Last Price | 2.59 |
| Change Percentage | -2.63% |
| Open | 2.66 |
| Previous Close | 2.66 |
| Market Cap ( Millions) | 207 |
| Volume | 8274 |
| Year High | 3.38 |
| Year Low | 2.3 |
| M A 50 | 2.64 |
| M A 200 | 2.77 |
Financial Ratios
| FCF Yield | 0.00% |
| Dividend Yield | 1.54% |
| ROE | 4.59% |
| Debt / Equity | 30.81% |
| Net Debt / EBIDTA | 148.12% |
| Price To Book | 1.0 |
| Price Earnings Ratio | 22.29 |
| Price To FCF | 0 |
| Price To sales | 0.62 |
| EV / EBITDA | 6.96 |
News
Business Breakdown
Expected Mid-Term Growth
Segment n°1 -> Pharmaceutical Services
Expected Growth : 6 %
What the company do ?
Pharmaceutical Services from Laboratorio Reig Jofre, S.A. provides development, manufacturing, and packaging of pharmaceutical products, including sterile injectables, ophthalmic solutions, and topical creams.
Why we expect these perspectives ?
Laboratorio Reig Jofre's Pharmaceutical Services segment growth of 6% is driven by increasing demand for specialty drugs, expansion into new markets, and strategic partnerships. Additionally, investments in digital health technologies and a strong pipeline of innovative products contribute to the segment's growth.
Segment n°2 -> Nutritional Supplements
Expected Growth : 8 %
What the company do ?
Nutritional Supplements from Laboratorio Reig Jofre, S.A. offer a range of high-quality products to support overall health and wellness, including vitamins, minerals, and herbal supplements.
Why we expect these perspectives ?
Strong demand for health and wellness products, increasing awareness of preventive healthcare, and rising disposable income drive growth in Nutritional Supplements from Laboratorio Reig Jofre, S.A. Additionally, expanding distribution channels, innovative product offerings, and strategic marketing efforts contribute to an 8% growth rate.
Laboratorio Reig Jofre, S.A. Products
| Product Range | What is it ? |
|---|---|
| Vaccines | Laboratorio Reig Jofre, S.A. develops and manufactures vaccines for various diseases, including influenza, pertussis, and others. |
| Biosimilars | The company offers a range of biosimilar products, including filgrastim, pegfilgrastim, and rituximab, for the treatment of cancer and autoimmune disorders. |
| Plasma Derivatives | Laboratorio Reig Jofre, S.A. manufactures plasma-derived products, including clotting factors, immunoglobulins, and albumin, for the treatment of bleeding disorders and immunodeficiencies. |
| Critical Care | The company offers a range of critical care products, including anesthetics, analgesics, and sedatives, for use in intensive care units and operating rooms. |
| Diagnostic Reagents | Laboratorio Reig Jofre, S.A. develops and manufactures diagnostic reagents for the detection of various diseases, including infectious diseases and cancer. |
Laboratorio Reig Jofre, S.A.'s Porter Forces
Threat Of Substitutes
Laboratorio Reig Jofre, S.A. faces moderate threat from substitutes due to the presence of alternative pharmaceutical products in the market.
Bargaining Power Of Customers
The bargaining power of customers is low due to the specialized nature of Laboratorio Reig Jofre, S.A.'s products, making it difficult for customers to switch to alternative suppliers.
Bargaining Power Of Suppliers
The bargaining power of suppliers is moderate due to the presence of multiple suppliers in the market, but Laboratorio Reig Jofre, S.A.'s large scale of operations gives it some negotiating power.
Threat Of New Entrants
The threat of new entrants is low due to the high barriers to entry in the pharmaceutical industry, including regulatory hurdles and high research and development costs.
Intensity Of Rivalry
The intensity of rivalry is high due to the presence of several established players in the pharmaceutical industry, leading to intense competition for market share.
Capital Structure
| Value | |
|---|---|
| Debt Weight | 20.02% |
| Debt Cost | 3.95% |
| Equity Weight | 79.98% |
| Equity Cost | 8.34% |
| WACC | 7.46% |
| Leverage | 25.03% |
Laboratorio Reig Jofre, S.A. : Quality Control
Laboratorio Reig Jofre, S.A. passed 5 out of 9 key points:
Historical Valuation
Price/Earnings Ratio
Margin Valuation
Peers Valuation
Competitors
| Company | Rational |
|---|---|
| PSG.DE | PharmaSGP Holding SE manufactures over-the-counter drugs, and other healthcare products in Germany. The company's pharmaceutical products include Baldriparan for the treatment of sleep disorders; Spalt, Formigran, and Kamol massage cream … |
| VETO.PA | Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas … |
| PPGN.SW | PolyPeptide Group AG operate as a contract development and manufacturing company worldwide. It focuses on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, … |
| SECARE.ST | Swedencare AB (publ), together with its subsidiaries, develops, manufactures, markets, and sells pet healthcare products. It offers ProDen PlaqueOff powder, a food supplement for cats and dogs, which reduce the … |
| BOI.PA | Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary, proprietary, branded homeopathic medicines. Its branded homeopathic medicines include Oscillococcinum … |
Peers Metrics
DCF BETA
Expected Cash-Flows
Scoring Insights
Peers Group Analysis
🥇
Reig Jofre
A-Score
1-Year Total Return ->
🥈
PharmaSGP Holding
A-Score
1-Year Total Return ->
🥉
Boiron
A-Score
1-Year Total Return ->
4
Vetoquinol
A-Score
1-Year Total Return ->
5
PolyPeptide
A-Score
1-Year Total Return ->
6
